Complete Filing Data
Marex Group plc reported Proceeds From Issue Of Ordinary Shares of 0 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Marex Group plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $0.00 | $0.00 | $800.0K | -$300.0K |
| Revenue From Interest | $912.8M | $765.2M | $591.8M | $194.4M |
| Profit Loss Before Tax | $411.6M | $295.8M | $196.5M | $121.6M |
| Profit Loss Attributable To Owners Of Parent | $293.9M | $204.7M | $128.0M | $91.6M |
| Profit Loss Attributable To Noncontrolling Interests | $500.0K | $0.00 | $0.00 | $6.6M |
| Profit Loss | $307.7M | $218.0M | $141.3M | $98.2M |
| Other Comprehensive Income Net Of Tax Gains Losses From Investments In Equity Instruments | -$900.0K | $3.4M | $0.00 | -$600.0K |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $6.7M | -$3.3M | $1.8M | $0.00 |
| Other Comprehensive Income Net Of Tax Deferred Tax On Gains Losses From Investments In Equity Instruments | $300.0K | -$900.0K | -$300.0K | $300.0K |
| Other Comprehensive Income Net Of Tax Deferred Tax On Change In Fair Value Of Financial Liability Attributable To Change In Credit Risk Of Liability | $0.00 | $4.0M | $1.7M | $1.2M |
| Other Comprehensive Income Net Of Tax Deferred Tax On Cash Flow Hedges | -$10.2M | $7.9M | -$300.0K | -$500.0K |
| Other Comprehensive Income Net Of Tax Change In Fair Value Of Financial Liability Attributable To Change In Credit Risk Of Liability | $0.00 | -$15.9M | -$6.4M | -$4.0M |
| Other Comprehensive Income Net Of Tax Cash Flow Hedges | $38.9M | -$29.7M | $1.2M | $2.7M |
| Other Comprehensive Income | $34.8M | -$34.5M | -$2.3M | -$900.0K |
| Interest Revenue Expense | $152.6M | $227.1M | $121.6M | $29.4M |
| Interest Expense | $760.2M | $538.1M | $470.2M | $165.0M |
| Income Taxes Paid Refund Classified As Operating Activities | $140.9M | $58.1M | $55.9M | $18.0M |
| Income Tax Expense Continuing Operations | $103.7M | $77.8M | $55.2M | $23.4M |
| Impairment Loss Recognised In Profit Or Loss Goodwill | $0.00 | $0.00 | $10.7M | $53.9M |
| Comprehensive Income Attributable To Owners Of Parent | $328.7M | $170.2M | $125.7M | $90.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | $500.0K | $0.00 | $0.00 | $6.6M |
| Comprehensive Income | $342.5M | $183.5M | $139.0M | $97.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | $2.88B | $2.56B | $1.48B | $910.1M | $712.0M |
| Rightofuse Assets | $76.9M | $59.9M | $40.6M | $33.7M | |
| Repayment Of Debt Securities Classified As Financing Activities | $6.3M | $0.00 | $0.00 | $50.0M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $13.1M | $11.7M | $9.0M | $3.6M | |
| Purchase Of Interests In Investments Accounted For Using Equity Method | $2.9M | $5.1M | $0.00 | $0.00 | |
| Purchase Of Intangible Assets Classified As Investing Activities | $6.7M | $8.2M | $3.1M | $5.8M | |
| Financial Assets Provision For Credit Losses | -$700.0K | -$1.7M | $7.1M | $9.5M | |
| Expense From Equitysettled Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets | $43.5M | $29.6M | $20.3M | $16.7M | |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $241.6M | $11.0M | $90.3M | $36.9M | |
| Cash Flows From Used In Operating Activities | $667.5M | $1.16B | $735.0M | $225.6M | |
| Cash Flows From Used In Investing Activities | -$264.3M | -$35.3M | -$97.6M | -$46.3M | |
| Cash Flows From Used In Financing Activities | -$123.9M | -$37.2M | -$72.8M | $26.5M | |
| Adjustments For Increase Decrease In Trade And Other Payables | $2.26B | $2.95B | -$709.5M | -$2.87B | |
| Adjustments For Increase Decrease In Repurchase Agreements And Cash Collateral On Securities Lent | $1.22B | -$103.7M | -$116.3M | $39.2M | |
| Adjustments For Increase Decrease In Financial Liabilities Held For Trading | $2.12B | $1.37B | $1.05B | $83.3M | |
| Adjustments For Decrease Increase In Trade And Other Receivables | -$2.57B | -$2.76B | $777.6M | $3.14B | |
| Adjustments For Decrease Increase In Financial Assets Measured At Fair Value Through Profit Or Loss | $6.8M | -$11.0M | -$76.7M | -$494.0M | |
| Adjustments For Decrease Increase In Financial Assets Measured At Amortised Cost | -$469.6M | -$663.1M | -$185.9M | $0.00 | |
| Adjustments For Decrease Increase In Equity Instruments Held | -$1.72B | -$3.38B | -$173.3M | -$402.3M | |
| Trade And Other Current Receivables | $10.99B | $7.55B | $4.79B | $4.69B | |
| Trade And Other Current Payables | $12.96B | $9.74B | $6.79B | $6.65B | |
| Reverse Repurchase Agreements And Cash Collateral On Securities Borrowed | $3.12B | $2.49B | $3.20B | $4.35B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Issue Of Ordinary Shares | 0.00 | 73.1M | 0.00 | 0.00 |
| Proceeds From Sales Of Investments Accounted For Using Equity Method | $0.00 | $700.0K | $0.00 | $0.00 |
| Proceeds From Sales Of Interests In Associates | $0.00 | $0.00 | $6.4M | $0.00 |
| Proceeds From Lease Incentive On Lease Liabilities | $0.00 | $6.4M | $0.00 | $0.00 |
| Payments To Acquire Or Redeem Entitys Shares | 44.1M | 19.8M | 3.1M | 7.9M |
| Payments Of Lease Liabilities Classified As Financing Activities | $18.0M | $15.0M | $11.4M | $6.6M |
| Payments For Contingent Consideration Liability | $0.00 | $0.00 | $1.6M | $0.00 |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $279.3M | $1.09B | $564.6M | $205.8M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $58.8M | -$17.9M | $8.8M | -$7.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $3.86 | $2.72 | $1.82 | $1.36 |
| Basic Earnings Loss Per Share | $4.12 | $2.96 | $1.94 | $1.39 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Trading Income Expense | $851.9M | $492.4M | $411.4M | $325.3M |
| Physical Commodities Income Expense | $42.1M | $19.1M | $6.7M | $4.6M |
| Payments From Issuance Costs Of Ordinary Shares | 0.00 | 4.8M | 0.00 | 0.00 |
| Other Income | $7.4M | $6.3M | $3.4M | $2.8M |
| Other Adjustments For Noncash Items | -$49.7M | $16.8M | -$6.6M | $0.00 |
| Interest Received Classified As Operating Activities | $908.9M | $768.3M | $595.0M | $159.2M |
| Interest Paid Classified As Operating Activities | $751.1M | $521.9M | $470.2M | $161.1M |
| Increase Decrease Through Sharebased Payment Transactions | $43.5M | $29.6M | $20.3M | $17.8M |
| Increase Decrease Through Other Distributions To Owners | $13.3M | $13.3M | $13.3M | $6.6M |
| Gain Recognised In Bargain Purchase Transaction | $3.6M | $0.00 | $300.0K | $71.6M |
| Fee And Commission Income Expense | $977.5M | $856.1M | $704.9M | $351.8M |
| Fee And Commission Income | $1.82B | $1.62B | $1.34B | $651.0M |
| Fee And Commission Expense | $845.5M | $762.0M | $637.5M | $299.2M |
| Employee Benefits Expense | $1.23B | $971.1M | $770.3M | $438.6M |
| Dividends Received Classified As Operating Activities | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends Paid Classified As Financing Activities | $55.5M | $77.1M | $58.3M | $6.6M |
| Depreciation And Amortisation Expense | $36.1M | $29.5M | $27.1M | $13.8M |
| Adjustments For Increase Decrease In Stock Borrowing And Lending | -$549.4M | $3.35B | $319.6M | $489.1M |
| Adjustments For Increase Decrease In Borrowings | $27.8M | $152.0M | -$148.7M | -$49.9M |
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | -$469.3M | $188.1M | $66.9M | -$111.1M |
| Adjustments For Decrease Increase In Inventories | -$422.0M | $127.6M | -$127.6M | $44.3M |
| Treasury Shares | 58.5M | 23.2M | 9.8M | 7.9M |
| Share Premium | $227.2M | $202.6M | $134.3M | $134.3M |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.